25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

0155 (Malaysian Genomics Resource) Stock Analysis
Buy, Hold or Sell?

Let's analyze Malaysian Genomics Resource together

I guess you are interested in Malaysian Genomics Resource. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • πŸ“Š Fundamental Analysis (FA) – Malaysian Genomics Resource’s Financial Insights
  • πŸ“ˆ Technical Analysis (TA) – Malaysian Genomics Resource’s Price Targets

I'm going to help you getting a better view of Malaysian Genomics Resource. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Malaysian Genomics Resource

I send you an email if I find something interesting about Malaysian Genomics Resource.

1. Quick Overview

1.1. Quick analysis of Malaysian Genomics Resource (30 sec.)










1.2. What can you expect buying and holding a share of Malaysian Genomics Resource? (30 sec.)

How much money do you get?

How much money do you get?
RM0.00
When do you have the money?
1 year
How often do you get paid?
8.3%

What is your share worth?

Current worth
RM0.12
Expected worth in 1 year
RM0.09
How sure are you?
50.0%

+ What do you gain per year?

Total Gains per Share
RM-0.03
Return On Investment
-12.7%

For what price can you sell your share?

Current Price per Share
RM0.22
Expected price per share
RM0.145 - RM0.245
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Malaysian Genomics Resource (5 min.)




Live pricePrice per Share (EOD)
RM0.22
Intrinsic Value Per Share
RM0.34 - RM0.44
Total Value Per Share
RM0.46 - RM0.56

2.2. Growth of Malaysian Genomics Resource (5 min.)




Is Malaysian Genomics Resource growing?

Current yearPrevious yearGrowGrow %
How rich?$3.9m$6m-$1.8m-43.1%

How much money is Malaysian Genomics Resource making?

Current yearPrevious yearGrowGrow %
Making money-$206.8k-$1m$886.5k428.6%
Net Profit Margin-65.4%-212.7%--

How much money comes from the company's main activities?

2.3. Financial Health of Malaysian Genomics Resource (5 min.)




2.4. Comparing to competitors in the Diagnostics & Research industry (5 min.)




  Industry Rankings (Diagnostics & Research)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Malaysian Genomics Resource?

Welcome investor! Malaysian Genomics Resource's management wants to use your money to grow the business. In return you get a share of Malaysian Genomics Resource.

First you should know what it really means to hold a share of Malaysian Genomics Resource. And how you can make/lose money.

Speculation

The Price per Share of Malaysian Genomics Resource is RM0.22. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Malaysian Genomics Resource.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Malaysian Genomics Resource, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is RM0.12. Based on the TTM, the Book Value Change Per Share is RM-0.01 per quarter. Based on the YOY, the Book Value Change Per Share is RM-0.04 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is RM0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Malaysian Genomics Resource.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 RM% of Price per ShareRM% of Price per ShareRM% of Price per ShareRM% of Price per ShareRM% of Price per ShareRM% of Price per Share
Usd Eps0.00-0.6%0.00-0.7%-0.01-3.6%0.00-1.8%0.00-0.9%0.000.0%
Usd Book Value Change Per Share0.00-0.6%0.00-0.8%-0.01-4.5%0.00-1.2%0.000.2%0.000.5%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.4%0.001.1%
Usd Total Gains Per Share0.00-0.6%0.00-0.8%-0.01-4.5%0.00-1.2%0.000.6%0.001.6%
Usd Price Per Share0.06-0.08-0.11-0.12-0.18-0.15-
Price to Earnings Ratio-11.01--14.78--7.64--6.27-22.40-5.45-
Price-to-Total Gains Ratio-39.84--52.19-3.68--4.27-4.55--4.86-
Price to Book Ratio1.97-2.60-2.47-2.57-5.33-4.47-
Price-to-Total Gains Ratio-39.84--52.19-3.68--4.27-4.55--4.86-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.051964
Number of shares19244
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.00
Usd Total Gains Per Share0.000.00
Gains per Quarter (19244 shares)-31.8423.50
Gains per Year (19244 shares)-127.3894.00
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-127-137672784
20-255-26413454178
30-382-39120181272
40-510-518268108366
50-637-645335135460
60-764-772401163554
70-892-899468190648
80-1019-1026535217742
90-1146-1153602244836
100-1274-1280669271930

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%2.09.00.018.2%7.012.00.036.8%8.016.00.033.3%8.016.00.033.3%
Book Value Change Per Share0.04.00.00.0%4.07.00.036.4%9.010.00.047.4%11.013.00.045.8%11.013.00.045.8%
Dividend per Share0.00.04.00.0%0.00.011.00.0%1.00.018.05.3%2.00.022.08.3%2.00.022.08.3%
Total Gains per Share0.04.00.00.0%4.07.00.036.4%10.09.00.052.6%12.012.00.050.0%12.012.00.050.0%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Malaysian Genomics Resource compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.006-0.007+16%-0.042+594%-0.011+79%0.001-504%0.005-218%
Book Value Per Share--0.1220.131-7%0.187-35%0.200-39%0.175-30%0.169-28%
Current Ratio--3.0833.599-14%9.190-66%10.660-71%13.057-76%11.482-73%
Debt To Asset Ratio--0.2210.209+6%0.141+57%0.153+45%0.135+63%0.186+19%
Debt To Equity Ratio--0.2730.256+7%0.165+65%0.181+50%0.160+71%0.298-8%
Dividend Per Share----0%-0%-0%0.004-100%0.010-100%
Enterprise Value--28177515.20042101648.300-33%58652676.533-52%69358466.618-59%110267924.200-74%101860523.173-72%
Eps---0.005-0.006+17%-0.034+519%-0.016+202%-0.008+47%0.000-96%
Ev To Sales Ratio--5.2227.870-34%7.062-26%9.967-48%36.270-86%32.920-84%
Free Cash Flow Per Share--0.0020.000+358%-0.010+658%-0.017+1069%-0.010+648%-0.006+432%
Free Cash Flow To Equity Per Share--0.0020.000+358%-0.010+677%-0.006+448%0.014-87%0.004-57%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--0.437----------
Intrinsic Value_10Y_min--0.337----------
Intrinsic Value_1Y_max---0.053----------
Intrinsic Value_1Y_min---0.052----------
Intrinsic Value_3Y_max---0.085----------
Intrinsic Value_3Y_min---0.083----------
Intrinsic Value_5Y_max---0.029----------
Intrinsic Value_5Y_min---0.033----------
Market Cap30186200.000-9%32930515.20046823076.300-30%62202009.867-47%70476144.073-53%106258296.937-69%89237941.325-63%
Net Profit Margin---0.554-0.654+18%-2.127+284%-1.191+115%-0.940+70%-0.780+41%
Operating Margin----0%-1.4900%-0.4560%-2.7990%-2.2350%
Operating Ratio--1.9002.058-8%1.587+20%2.128-11%3.062-38%2.946-36%
Pb Ratio1.803-9%1.9662.596-24%2.465-20%2.569-23%5.328-63%4.475-56%
Pe Ratio-10.089+8%-11.006-14.783+34%-7.645-31%-6.272-43%22.399-149%5.448-302%
Price Per Share0.220-9%0.2400.341-30%0.453-47%0.514-53%0.749-68%0.631-62%
Price To Free Cash Flow Ratio30.802-9%33.603-25.773+177%-8.203+124%-19.523+158%-5.419+116%-6.443+119%
Price To Total Gains Ratio-36.522+8%-39.842-52.191+31%3.677-1184%-4.271-89%4.552-975%-4.863-88%
Quick Ratio--2.5972.753-6%8.260-69%9.957-74%12.509-79%11.003-76%
Return On Assets---0.035-0.038+10%-0.152+338%-0.054+54%0.033-207%0.043-181%
Return On Equity---0.043-0.047+9%-0.177+311%-0.063+47%0.029-246%0.039-210%
Total Gains Per Share---0.006-0.007+16%-0.042+594%-0.011+79%0.005-217%0.015-140%
Usd Book Value--3955405.2004232203.197-7%6057191.533-35%6485708.200-39%5743825.064-31%5522277.483-28%
Usd Book Value Change Per Share---0.001-0.002+16%-0.010+594%-0.003+79%0.000-504%0.001-218%
Usd Book Value Per Share--0.0290.031-7%0.044-35%0.047-39%0.041-30%0.040-28%
Usd Dividend Per Share----0%-0%-0%0.001-100%0.002-100%
Usd Enterprise Value--6655529.0909944409.328-33%13853762.197-52%16382469.815-59%26045283.696-74%24059455.573-72%
Usd Eps---0.001-0.002+17%-0.008+519%-0.004+202%-0.002+47%0.000-96%
Usd Free Cash Flow--57869.00012632.626+358%-215335.667+472%-509651.832+981%-181917.809+414%-90549.150+256%
Usd Free Cash Flow Per Share--0.0000.000+358%-0.002+658%-0.004+1069%-0.002+648%-0.001+432%
Usd Free Cash Flow To Equity Per Share--0.0000.000+358%-0.002+677%-0.001+448%0.003-87%0.001-57%
Usd Market Cap7129980.440-9%7778187.69011059610.622-30%14692114.731-47%16646465.230-53%25098209.736-69%21078001.741-63%
Usd Price Per Share0.052-9%0.0570.081-30%0.107-47%0.121-53%0.177-68%0.149-62%
Usd Profit---176677.600-206852.150+17%-1093369.800+519%-356631.079+102%-34486.567-80%171826.180-203%
Usd Revenue--318633.800316626.100+1%493500.533-35%517438.831-38%630409.719-49%762290.041-58%
Usd Total Gains Per Share---0.001-0.002+16%-0.010+594%-0.003+79%0.001-217%0.004-140%
 EOD+4 -4MRQTTM+20 -15YOY+18 -173Y+19 -165Y+10 -2710Y+9 -28

3.3 Fundamental Score

Let's check the fundamental score of Malaysian Genomics Resource based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-10.089
Price to Book Ratio (EOD)Between0-11.803
Net Profit Margin (MRQ)Greater than0-0.554
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than12.597
Current Ratio (MRQ)Greater than13.083
Debt to Asset Ratio (MRQ)Less than10.221
Debt to Equity Ratio (MRQ)Less than10.273
Return on Equity (MRQ)Greater than0.15-0.043
Return on Assets (MRQ)Greater than0.05-0.035
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of Malaysian Genomics Resource based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5053.817
Ma 20Greater thanMa 500.215
Ma 50Greater thanMa 1000.227
Ma 100Greater thanMa 2000.239
OpenGreater thanClose0.185
Total1/5 (20.0%)

4. In-depth Analysis

4.1 About Malaysian Genomics Resource

Malaysian Genomics Resource Centre Berhad, together with its subsidiaries, provides genetics, genomics, immunotherapy, and biopharmaceutical services worldwide. Its flagship product, Dtect genetic screening tests, inspects DNA for markers associated with genetic variations that influence various biological processes. The company offers genome sequencing services for humans, animals, and microbes and other living organisms; transcriptome sequencing; and metagenomics and metatranscriptomics. It also offers genome analysis services, including bioinformatics, trait analysis, and trio sequencing; genetic screening services, such as Dtect and Origene genetic screening test; and CAR T-cell immunotherapy treatment for different types of cancer. In addition, the company is involved in dealing in capital markets and derivative instruments; acting as general merchants; and provision of system developments and information technology. It has a research collaboration with Universiti Sains Malaysia for exploring the genetics of Penang Woman and determining the age of the ancient Penang Women Skeleton using the Accelerator Mass Spectrometry dating technique. Malaysian Genomics Resource Centre Berhad was incorporated in 2004 and is headquartered in Petaling Jaya, Malaysia.

Fundamental data was last updated by Penke on 2025-06-27 21:59:05.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profitΒ Malaysian Genomics Resource earns for each RM1 of revenue.

  • Above 10% is considered healthy but always compareΒ Malaysian Genomics Resource to theΒ Diagnostics & Research industry mean.
  • A Net Profit Margin of -55.4%Β means thatΒ RM-0.55 for each RM1Β in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Malaysian Genomics Resource:

  • The MRQ is -55.4%. The company is making a huge loss. -2
  • The TTM is -65.4%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-55.4%TTM-65.4%+10.0%
TTM-65.4%YOY-212.7%+147.3%
TTM-65.4%5Y-94.0%+28.6%
5Y-94.0%10Y-78.0%-16.0%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-55.4%-5.0%-50.4%
TTM-65.4%-5.8%-59.6%
YOY-212.7%-9.0%-203.7%
3Y-119.1%-8.5%-110.6%
5Y-94.0%-4.9%-89.1%
10Y-78.0%-1.8%-76.2%
4.3.1.2. Return on Assets

Shows howΒ efficientΒ Malaysian Genomics Resource is using its assets to generate profit.

  • Above 5% is considered healthyΒ but always compareΒ Malaysian Genomics Resource to theΒ Diagnostics & Research industry mean.
  • -3.5% Return on Assets means thatΒ Malaysian Genomics Resource generatedΒ RM-0.03 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Malaysian Genomics Resource:

  • The MRQ is -3.5%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -3.8%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-3.5%TTM-3.8%+0.4%
TTM-3.8%YOY-15.2%+11.4%
TTM-3.8%5Y3.3%-7.1%
5Y3.3%10Y4.3%-1.0%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.5%-0.7%-2.8%
TTM-3.8%-0.8%-3.0%
YOY-15.2%-1.3%-13.9%
3Y-5.4%-1.4%-4.0%
5Y3.3%-0.1%+3.4%
10Y4.3%0.1%+4.2%
4.3.1.3. Return on Equity

Shows how efficient Malaysian Genomics Resource is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compareΒ Malaysian Genomics Resource to theΒ Diagnostics & Research industry mean.
  • -4.3% Return on Equity means Malaysian Genomics Resource generated RM-0.04Β for eachΒ RM1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Malaysian Genomics Resource:

  • The MRQ is -4.3%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -4.7%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-4.3%TTM-4.7%+0.4%
TTM-4.7%YOY-17.7%+13.0%
TTM-4.7%5Y2.9%-7.6%
5Y2.9%10Y3.9%-1.0%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-4.3%-0.8%-3.5%
TTM-4.7%-0.8%-3.9%
YOY-17.7%-2.0%-15.7%
3Y-6.3%-1.7%-4.6%
5Y2.9%-1.1%+4.0%
10Y3.9%-1.4%+5.3%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Malaysian Genomics Resource.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

MeasuresΒ how efficient Malaysian Genomics Resource is operatingΒ .

  • Measures how much profit Malaysian Genomics Resource makes for each RM1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compareΒ Malaysian Genomics Resource to theΒ Diagnostics & Research industry mean.
  • An Operating Margin of 0.0%Β means the company generated RM0.00 Β for each RM1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Malaysian Genomics Resource:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-149.0%+149.0%
TTM-5Y-279.9%+279.9%
5Y-279.9%10Y-223.5%-56.4%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.6%-3.6%
TTM--10.7%+10.7%
YOY-149.0%-8.5%-140.5%
3Y-45.6%-1.7%-43.9%
5Y-279.9%3.2%-283.1%
10Y-223.5%4.0%-227.5%
4.3.2.2. Operating Ratio

Measures how efficient Malaysian Genomics Resource is keepingΒ operating costsΒ low.

  • Below 1 is considered healthy (always compare toΒ Diagnostics & Research industry mean).
  • An Operation Ratio of 1.90 means that the operating costs are RM1.90 for each RM1 in net sales.

Let's take a look of the Operating Ratio trends of Malaysian Genomics Resource:

  • The MRQ is 1.900. The company is inefficient in keeping operating costs low. -1
  • The TTM is 2.058. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.900TTM2.058-0.158
TTM2.058YOY1.587+0.470
TTM2.0585Y3.062-1.004
5Y3.06210Y2.946+0.116
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ1.9001.420+0.480
TTM2.0581.302+0.756
YOY1.5871.292+0.295
3Y2.1281.284+0.844
5Y3.0621.277+1.785
10Y2.9461.192+1.754
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Malaysian Genomics Resource.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Malaysian Genomics Resource is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare toΒ Diagnostics & Research industry mean).
  • A Current Ratio of 3.08Β means the company has RM3.08 in assets for each RM1 in short-term debts.

Let's take a look of the Current Ratio trends of Malaysian Genomics Resource:

  • The MRQ is 3.083. The company is very able to pay all its short-term debts. +2
  • The TTM is 3.599. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ3.083TTM3.599-0.516
TTM3.599YOY9.190-5.591
TTM3.5995Y13.057-9.458
5Y13.05710Y11.482+1.575
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ3.0832.037+1.046
TTM3.5992.055+1.544
YOY9.1902.374+6.816
3Y10.6602.414+8.246
5Y13.0572.552+10.505
10Y11.4822.974+8.508
4.4.3.2. Quick Ratio

Measures if Malaysian Genomics Resource is able to pay off Short-term Debt but only usingΒ theΒ most liquid assets.

  • Above 1 is considered healthy butΒ always compareΒ Malaysian Genomics Resource to theΒ Diagnostics & Research industry mean.
  • A Quick Ratio of 2.60Β means the company can pay off RM2.60 for each RM1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Malaysian Genomics Resource:

  • The MRQ is 2.597. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 2.753. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ2.597TTM2.753-0.156
TTM2.753YOY8.260-5.507
TTM2.7535Y12.509-9.756
5Y12.50910Y11.003+1.506
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ2.5971.084+1.513
TTM2.7531.132+1.621
YOY8.2601.354+6.906
3Y9.9571.538+8.419
5Y12.5091.803+10.706
10Y11.0032.090+8.913
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Malaysian Genomics Resource.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much %Β of Malaysian Genomics ResourceΒ assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compareΒ Malaysian Genomics Resource to Diagnostics & Research industry mean.
  • A Debt to Asset Ratio of 0.22Β means that Malaysian Genomics Resource assets areΒ financed with 22.1% credit (debt) and the remaining percentage (100% - 22.1%)Β is financed by its owners/shareholders.Β 

Let's take a look of the Debt to Asset Ratio trends of Malaysian Genomics Resource:

  • The MRQ is 0.221. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.209. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.221TTM0.209+0.012
TTM0.209YOY0.141+0.068
TTM0.2095Y0.135+0.073
5Y0.13510Y0.186-0.050
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2210.385-0.164
TTM0.2090.432-0.223
YOY0.1410.390-0.249
3Y0.1530.389-0.236
5Y0.1350.410-0.275
10Y0.1860.454-0.268
4.5.4.2. Debt to Equity Ratio

Measures ifΒ Malaysian Genomics Resource is able toΒ pay off its debts by usingΒ shareholders equity.

  • Below 2 is considered healthy butΒ always compareΒ Malaysian Genomics Resource to theΒ Diagnostics & Research industry mean.
  • A Debt to Equity ratio of 27.3% means that company has RM0.27 debt for each RM1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Malaysian Genomics Resource:

  • The MRQ is 0.273. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.256. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.273TTM0.256+0.017
TTM0.256YOY0.165+0.091
TTM0.2565Y0.160+0.096
5Y0.16010Y0.298-0.138
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2730.604-0.331
TTM0.2560.612-0.356
YOY0.1650.589-0.424
3Y0.1810.702-0.521
5Y0.1600.674-0.514
10Y0.2980.657-0.359
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

MeasuresΒ how much money you payΒ for each share forΒ every RM1 in earnings Malaysian Genomics Resource generates.

  • Above 15 is considered overpriced butΒ always compareΒ Malaysian Genomics Resource to theΒ Diagnostics & Research industry mean.
  • A PE ratio of -11.01 means the investor is paying RM-11.01Β for every RM1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Malaysian Genomics Resource:

  • The EOD is -10.089. Based on the earnings, the company is expensive. -2
  • The MRQ is -11.006. Based on the earnings, the company is expensive. -2
  • The TTM is -14.783. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-10.089MRQ-11.006+0.917
MRQ-11.006TTM-14.783+3.777
TTM-14.783YOY-7.645-7.139
TTM-14.7835Y22.399-37.182
5Y22.39910Y5.448+16.950
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD-10.089-0.557-9.532
MRQ-11.006-0.732-10.274
TTM-14.783-0.477-14.306
YOY-7.645-0.134-7.511
3Y-6.272-0.087-6.185
5Y22.3995.675+16.724
10Y5.4487.829-2.381
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Malaysian Genomics Resource:

  • The EOD is 30.802. Based on how much money comes from the company's main activities, the company is fair priced.
  • The MRQ is 33.603. Based on how much money comes from the company's main activities, the company is fair priced.
  • The TTM is -25.773. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD30.802MRQ33.603-2.800
MRQ33.603TTM-25.773+59.376
TTM-25.773YOY-8.203-17.570
TTM-25.7735Y-5.419-20.354
5Y-5.41910Y-6.443+1.024
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD30.802-1.003+31.805
MRQ33.603-1.081+34.684
TTM-25.773-0.557-25.216
YOY-8.203-1.053-7.150
3Y-19.523-0.440-19.083
5Y-5.419-0.670-4.749
10Y-6.443-0.654-5.789
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price ofΒ Malaysian Genomics Resource is to cheap or to expensiveΒ compared to its book value.

  • At or below 1 is considered healthyΒ (always compare to Diagnostics & Research industry mean).
  • A PB ratio of 1.97 means the investor is paying RM1.97Β for each RM1 in book value.

Let's take a look of the Price to Book Ratio trends of Malaysian Genomics Resource:

  • The EOD is 1.803. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.966. Based on the equity, the company is underpriced. +1
  • The TTM is 2.596. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.803MRQ1.966-0.164
MRQ1.966TTM2.596-0.630
TTM2.596YOY2.465+0.131
TTM2.5965Y5.328-2.731
5Y5.32810Y4.475+0.853
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD1.8031.929-0.126
MRQ1.9662.072-0.106
TTM2.5962.188+0.408
YOY2.4652.305+0.160
3Y2.5692.476+0.093
5Y5.3283.509+1.819
10Y4.4754.355+0.120
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2025-03-31. Currency in MYR. All numbers in thousands.

Summary
Total Assets21,499
Total Liabilities4,753
Total Stockholder Equity17,408
 As reported
Total Liabilities 4,753
Total Stockholder Equity+ 17,408
Total Assets = 21,499

Assets

Total Assets21,499
Total Current Assets11,106
Long-term Assets10,393
Total Current Assets
Cash And Cash Equivalents 446
Net Receivables 9,356
Inventory 846
Other Current Assets 196
Total Current Assets  (as reported)11,106
Total Current Assets  (calculated)10,844
+/- 262
Long-term Assets
Property Plant Equipment 4,119
Long-term Assets  (as reported)10,393
Long-term Assets  (calculated)4,119
+/- 6,274

Liabilities & Shareholders' Equity

Total Current Liabilities3,602
Long-term Liabilities1,151
Total Stockholder Equity17,408
Total Current Liabilities
Accounts payable 3,200
Total Current Liabilities  (as reported)3,602
Total Current Liabilities  (calculated)3,200
+/- 402
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt1,515
Long-term Liabilities  (as reported)1,151
Long-term Liabilities  (calculated)1,515
+/- 364
Total Stockholder Equity
Total Stockholder Equity (as reported)17,408
Total Stockholder Equity (calculated)0
+/- 17,408
Other
Capital Stock59,436
Common Stock Shares Outstanding 137,210
Net Invested Capital 17,408
Net Working Capital 7,504
Property Plant and Equipment Gross 4,119



6.2. Balance Sheets Structured

Currency in MYR. All numbers in thousands.

 Trend2025-03-312024-12-312024-09-302024-06-302024-03-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-31
> Total Assets 
38,530
37,003
37,068
41,132
14,217
11,086
10,878
9,132
21,348
22,783
36,028
33,068
35,105
41,889
42,484
45,131
42,110
30,873
33,716
24,685
23,862
22,841
22,355
21,499
21,49922,35522,84123,86224,68533,71630,87342,11045,13142,48441,88935,10533,06836,02822,78321,3489,13210,87811,08614,21741,13237,06837,00338,530
   > Total Current Assets 
15,018
13,663
13,642
41,078
14,174
9,206
7,963
6,092
18,420
15,663
28,982
26,054
27,894
30,062
29,303
32,810
30,950
21,427
23,792
15,296
14,860
11,707
11,588
11,106
11,10611,58811,70714,86015,29623,79221,42730,95032,81029,30330,06227,89426,05428,98215,66318,4206,0927,9639,20614,17441,07813,64213,66315,018
       Cash And Cash Equivalents 
5,361
4,210
3,817
36,258
9,508
0
6,811
4,122
13,544
11,309
21,477
22,184
22,385
20,518
7,848
3,467
3,581
1,693
3,685
436
239
67
271
446
446271672394363,6851,6933,5813,4677,84820,51822,38522,18421,47711,30913,5444,1226,81109,50836,2583,8174,2105,361
       Net Receivables 
7,444
6,889
8,151
4,708
4,514
2,953
959
1,828
4,787
3,953
6,775
2,853
5,129
9,110
20,702
28,730
26,633
19,164
19,446
13,477
13,282
10,452
4,330
9,356
9,3564,33010,45213,28213,47719,44619,16426,63328,73020,7029,1105,1292,8536,7753,9534,7871,8289592,9534,5144,7088,1516,8897,444
       Inventory 
1,988
1,585
1,508
65
90
84
68
56
37
307
639
939
277
383
554
449
521
435
494
914
899
844
937
846
8469378448999144944355214495543832779396393073756688490651,5081,5851,988
       Other Current Assets 
63
10
7
4
12
55
87
42
3
40
31
13
58
269
199
164
130
135
111
309
256
135
251
196
19625113525630911113513016419926958133140342875512471063
   > Long-term Assets 
23,512
23,340
23,426
54
43
0
2,915
3,040
2,928
7,120
7,046
7,014
7,211
11,828
13,181
12,321
11,160
0
9,924
9,389
9,002
11,134
10,768
10,393
10,39310,76811,1349,0029,3899,924011,16012,32113,18111,8287,2117,0147,0467,1202,9283,0402,9150435423,42623,34023,512
       Property Plant Equipment 
14,479
14,314
14,408
54
43
36
1,094
1,242
1,153
5,368
5,317
5,308
5,528
5,797
5,574
5,301
5,196
4,941
5,525
5,200
4,919
4,656
4,388
4,119
4,1194,3884,6564,9195,2005,5254,9415,1965,3015,5745,7975,5285,3085,3175,3681,1531,2421,09436435414,40814,31414,479
       Goodwill 
0
8,828
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000008,8280
       Intangible Assets 
9,033
197
9,018
0
0
1,844
1,821
1,798
1,775
1,752
1,729
1,706
1,683
4,950
4,927
4,908
4,884
4,505
0
0
0
0
3,880
0
03,88000004,5054,8844,9084,9274,9501,6831,7061,7291,7521,7751,7981,8211,844009,0181979,033
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
1,080
1,080
1,080
1,080
0
0
0
0
0
0
0
00000001,0801,0801,0801,0800000000000000
> Total Liabilities 
21,255
21,073
21,353
3,836
1,356
828
1,453
1,261
1,052
4,853
5,953
1,982
2,055
4,843
4,558
4,464
4,310
4,084
4,163
4,094
4,682
4,668
4,783
4,753
4,7534,7834,6684,6824,0944,1634,0844,3104,4644,5584,8432,0551,9825,9534,8531,0521,2611,4538281,3563,83621,35321,07321,255
   > Total Current Liabilities 
6,458
7,068
6,637
3,836
1,356
828
816
723
612
3,551
4,720
818
961
1,663
1,505
1,549
1,869
1,790
2,461
2,578
3,262
3,344
3,557
3,602
3,6023,5573,3443,2622,5782,4611,7901,8691,5491,5051,6639618184,7203,5516127238168281,3563,8366,6377,0686,458
       Short-term Debt 
3,918
4,002
2,960
2,602
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000002,6022,9604,0023,918
       Short Long Term Debt 
3,918
4,002
2,960
2,602
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000002,6022,9604,0023,918
       Accounts payable 
2,490
1,748
3,279
1,234
1,356
0
444
316
211
7
4,387
502
686
69
1,065
1,128
1,404
1,325
1,893
2,048
2,721
2,900
288
3,200
3,2002882,9002,7212,0481,8931,3251,4041,1281,065696865024,387721131644401,3561,2343,2791,7482,490
       Other Current Liabilities 
50
0
0
0
0
0
0
0
0
0
0
0
0
0
69
43
0
75
0
0
0
0
0
0
0000007504369000000000000050
   > Long-term Liabilities 
14,797
14,005
14,716
0
0
0
637
538
440
1,302
1,233
1,164
1,094
1,259
1,164
1,067
969
0
1,702
1,516
1,420
1,324
1,226
1,151
1,1511,2261,3241,4201,5161,70209691,0671,1641,2591,0941,1641,2331,30244053863700014,71614,00514,797
       Long term Debt Total 
14,121
13,268
13,982
0
0
0
637
538
440
1,302
1,233
1,164
1,094
1,259
1,164
1,067
969
869
0
0
0
0
0
0
0000008699691,0671,1641,2591,0941,1641,2331,30244053863700013,98213,26814,121
> Total Stockholder Equity
17,275
15,930
15,715
37,296
12,861
10,258
9,425
7,871
20,296
17,930
30,075
31,086
33,050
37,046
37,926
40,667
37,800
26,789
28,169
20,939
19,606
18,678
18,155
17,408
17,40818,15518,67819,60620,93928,16926,78937,80040,66737,92637,04633,05031,08630,07517,93020,2967,8719,42510,25812,86137,29615,71515,93017,275
   Common Stock
28,489
28,489
28,489
28,489
28,489
28,489
28,489
28,489
40,714
40,714
52,684
52,684
52,684
52,620
52,620
56,608
56,608
56,608
0
0
0
0
0
0
00000056,60856,60856,60852,62052,62052,68452,68452,68440,71440,71428,48928,48928,48928,48928,48928,48928,48928,489
   Retained Earnings 
-11,214
-12,559
-12,774
8,807
-15,628
-18,231
-19,064
-20,618
-20,418
-22,784
-22,609
-21,598
-19,634
-15,574
-14,694
-15,926
-18,808
-29,819
-31,267
-38,497
-39,830
-40,758
-41,280
-42,028
-42,028-41,280-40,758-39,830-38,497-31,267-29,819-18,808-15,926-14,694-15,574-19,634-21,598-22,609-22,784-20,418-20,618-19,064-18,231-15,6288,807-12,774-12,559-11,214
   Capital Surplus 000000000000000000000000
   Treasury Stock000000000000000000000000
   Other Stockholders Equity 00000000-15000000000000000



6.3. Balance Sheets

Currency in MYR. All numbers in thousands.




6.4. Cash Flows

Currency in MYR. All numbers in thousands.




6.5. Income Statements

Currency in MYR. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2023-06-30. Currency in MYR. All numbers in thousands.

Gross Profit (+$)
totalRevenue8,364
Cost of Revenue-3,264
Gross Profit5,1005,100
 
Operating Income (+$)
Gross Profit5,100
Operating Expense-12,480
Operating Income-13,589-7,380
 
Operating Expense (+$)
Research Development0
Selling General Administrative11,116
Selling And Marketing Expenses0
Operating Expense12,48011,116
 
Net Interest Income (+$)
Interest Income0
Interest Expense-96
Other Finance Cost-3
Net Interest Income-99
 
Pretax Income (+$)
Operating Income-13,589
Net Interest Income-99
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-13,589-13,589
EBIT - interestExpense = -13,650
-13,093
-14,150
Interest Expense96
Earnings Before Interest and Taxes (EBIT)-13,554-13,493
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax-13,589
Tax Provision-1,153
Net Income From Continuing Ops5,534-14,742
Net Income-14,246
Net Income Applicable To Common Shares-14,246
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net099
 

Technical Analysis of Malaysian Genomics Resource
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Malaysian Genomics Resource. The general trend of Malaysian Genomics Resource is BEARISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Malaysian Genomics Resource's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-71.4%) Bearish trend (71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Malaysian Genomics Resource Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

SupportΒ is a price level at which demand for an asset is strong enough to prevent the price from falling further.
ResistanceΒ is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Malaysian Genomics Resource.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 0.19 < 0.245 < 0.245.

The bearish price targets are: 0.145 > 0.145.

Know someone who trades $0155? Share this with them.πŸ‘‡

Malaysian Genomics Resource Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows theΒ moving averageΒ of the selected period.

  • Moving averages are laggingΒ trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Malaysian Genomics Resource. The current mas is .

The long score for the Moving Averages is 2/14.
The longshort score for the Moving Averages is -10/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Malaysian Genomics Resource Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows theΒ momentumΒ of theΒ selected period based on two moving averages.

  • MACD is aΒ lagging momentumΒ indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Malaysian Genomics Resource. The current macd is -0.00754311.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Malaysian Genomics Resource price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Malaysian Genomics Resource. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Malaysian Genomics Resource price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Malaysian Genomics Resource Daily Moving Average Convergence/Divergence (MACD) ChartMalaysian Genomics Resource Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Malaysian Genomics Resource. The current adx is 18.12.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Malaysian Genomics Resource shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Malaysian Genomics Resource Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • ShowsΒ the current trend.
  • ShowsΒ potential entry signals.
  • ShowsΒ Β potential exit signals.
  • Can be used to placeΒ trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Malaysian Genomics Resource. The current sar is 0.22535314.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Malaysian Genomics Resource Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentumΒ indicator, meaning the signals are instant.
  • RangesΒ between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Malaysian Genomics Resource. The current rsi is 53.82. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
  • Trending up: The RSI is trending up. +1
Malaysian Genomics Resource Daily Relative Strength Index (RSI) ChartMalaysian Genomics Resource Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

ComparesΒ a certain price to multiple prices ranging over time.

  • LeadingΒ momentumΒ indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • RangesΒ between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Malaysian Genomics Resource. The current phase is Overbought in bear market.

The long score for the Stochastic Oscillator is 6/6.
The longshort score for the Stochastic Oscillator is 6/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Malaysian Genomics Resource price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Malaysian Genomics Resource Daily Stochastic Oscillator ChartMalaysian Genomics Resource Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,Β the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Malaysian Genomics Resource. The current cci is -23.58974359.

Malaysian Genomics Resource Daily Commodity Channel Index (CCI) ChartMalaysian Genomics Resource Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Malaysian Genomics Resource. The current cmo is 18.92.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Malaysian Genomics Resource Daily Chande Momentum Oscillator (CMO) ChartMalaysian Genomics Resource Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

Β Shows the current price relative to the highest high over the last 14 days.
Β 

  • Lagging momentum indicator
  • Ranging between 0 andΒ -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Malaysian Genomics Resource. The current willr is -12.5.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Malaysian Genomics Resource Daily Williams %R ChartMalaysian Genomics Resource Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversoldΒ 

Score

Let's take a look at the Bollinger Bands of Malaysian Genomics Resource.

Malaysian Genomics Resource Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Malaysian Genomics Resource. The current atr is 0.01113475.

Malaysian Genomics Resource Daily Average True Range (ATR) ChartMalaysian Genomics Resource Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

Β Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Malaysian Genomics Resource. The current obv is 36,560,600.

Malaysian Genomics Resource Daily On-Balance Volume (OBV) ChartMalaysian Genomics Resource Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Malaysian Genomics Resource. The current mfi is 16.10.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
Malaysian Genomics Resource Daily Money Flow Index (MFI) ChartMalaysian Genomics Resource Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Malaysian Genomics Resource.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-02-10CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-02-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-02-13STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-14CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-02-17STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-02-18SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-02-19STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-20STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-02-21WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-02-25STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-02-27MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-03-03SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-03-05STOCH SHORT EXITThe %K line crosses above the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-07STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-03-20STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-24STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-25CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-03-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-03-28STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-02RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-03STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-04-07MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-08STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-10STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-14STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-16ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-17RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-18STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-04-22RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-24MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-25DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-04-28STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-05-02STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-05STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-08STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-13STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-16STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-19STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-05-20SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-21MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-05-23CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-05-26BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-05-27DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-05-28STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-29MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-05-30MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-06-05MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-06-06STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-06-09STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-06-10MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-06-11WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-06-16STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-17CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-06-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-06-23MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-24STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-25STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-07-02MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-07-03CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-07-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).

6.3. Candlestick Patterns

Malaysian Genomics Resource Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Malaysian Genomics Resource based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5053.817
Ma 20Greater thanMa 500.215
Ma 50Greater thanMa 1000.227
Ma 100Greater thanMa 2000.239
OpenGreater thanClose0.185
Total1/5 (20.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Malaysian Genomics Resource with someone you think should read this too:
  • Are you bullish or bearish on Malaysian Genomics Resource? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Malaysian Genomics Resource? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Malaysian Genomics Resource

I send you an email if I find something interesting about Malaysian Genomics Resource.


Comments

How you think about this?

Leave a comment

Stay informed about Malaysian Genomics Resource.

Receive notifications about Malaysian Genomics Resource in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.